Q32 Bio Inc. Common Stock (QTTB) is a publicly traded Healthcare sector company. As of September 4, 2026, QTTB trades at $13.00 with a market cap of $404.57M and a P/E ratio of 5.31. QTTB moved +1.56% today. Year to date, QTTB is +272.09%; over the trailing twelve months it is +671.08%. Its 52-week range spans $1.35 to $23.57. Analyst consensus is strong buy with an average price target of $41.00. Rallies surfaces QTTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for QTTB, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $13.00 |
| Market Cap | $404.57M |
| P/E Ratio | 5.31 |
| EPS | $2.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.57 |
| 52-Week Low | $1.35 |
| Volume | 3.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $53.74M |
| Net Income | $29.82M |
| Gross Margin | 0.00% |
5 analysts cover QTTB: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.00.